Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
ZEISS advances cataract and corneal refractive surgical care with new workflow innovations 2023-08-31 21:00
CANbridge Announces Interim Financial Results and Corporate Updates for the Six Months Ended June 30, 2023 2023-08-31 15:15
Tycoon Group Announces 2023 Interim Results 2023-08-31 13:28
Zylox-Tonbridge's ZENFlow Tiger™ LD PTA Dilatation Catheter Receives ANVISA Marketing Approval 2023-08-31 11:31
Sirnaomics Announces Successful Phase I Clinical Study of RNAi Therapeutic STP707 for Treatment of Multiple Solid Tumors 2023-08-31 11:30
Sirnaomics Announces 2023 Interim Results 2023-08-31 10:40
LOTTE BIOLOGICS Holds 'ESG Declaration Ceremony' 2023-08-31 09:00
Broncus Medical (02216.HK) Announces Interim Results for 2023 2023-08-30 23:49
The Menarini Group Announces ELZONRIS® (Tagraxofusp) Designated as an Orphan Drug for BPDCN by Japanese Ministry of Health, Labor and Welfare 2023-08-30 23:15
Jacobio Pharma Announces 2023 Interim Results 2023-08-30 21:45
European Society of Cardiology Congress: Traditional Chinese Medicine Qili Qiangxin significantly reduces the risk of cardiovascular death and re-hospitalization due to heart failure 2023-08-30 20:11
LifeTech Scientific Corporation (1302.HK) Announces 2023 Interim Results 2023-08-30 19:39
Igniting Innovation, Catalyzing Changes: Bio Farma x MIT Hacking Medicine Hackathon Celebrates Success 2023-08-30 16:16
GC Biopharma to organize "Donate Blood with Love", a healthy way of giving back to the community 2023-08-30 16:05
Asieris Obtained IND Approval from NMPA for APL-1401, a Drug for the Treatment of Moderately-to-Severely Active Ulcerative Colitis 2023-08-30 14:19
Mindray Introduces Innovative Upgrades to A Series Anaesthesia Systems for Enhanced Patient Safety and Efficiency 2023-08-30 11:07
InxMed Receives Approval to Initiate Phase I Clinical Trial in China for OMTX705, a First-in-Class FAP-Targeting ADC 2023-08-30 11:00
Fosun Pharma Announces 2023 Interim Results: Continues to Promote Innovation Transformation and Optimizes Product Structure 2023-08-30 10:53
Akeso Announced 2023 Interim Results: First Profit, Growing Sales of PD-1/CTLA-4 Bispecific Antibody and Priority Review of PD-1/VEGF 2023-08-30 08:03
Epigenic Therapeutics Announces $32 Million in Series A Funding to Bring Breakthrough Epigenome Medicine to Clinical Development 2023-08-30 08:00
1 159 160 161 162 163 969